MNPR Stock-Based Compensation

Monopar Therapeutics Inc · Stock-Based Compensation

MNPR logo

MNPR Stock-Based Compensation

Latest reported$1.43B
MNPR Stock-Based Comp ($0.00 → $1.43B)
High-resolution chart · PNG

MNPR stock-based compensation history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Monopar Therapeutics Inc Stock-Based Compensation — Annual fiscal periods (USD)
Period endingStock-Based Compensation (USD)
4,837,877
1,140,785
1,897,849
1,641,263
1,468,054
1,320,890
1,011,170
529,332
305,205
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.